DREAMM 7 Belantamab Combo
DREAMM-7 Efficacy Update: Belantamab Mafodotin Plus Bortezomib, Dexamethasone vs Daratumumab Plus Bortezomib, Dexamethasone in Relapsed/Refractory Multiple Myeloma

Released: December 11, 2024

Expiration: December 10, 2025

Activity

Progress
1
Course Completed